ArticleThe Journal of experimental medicine2024

NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer.

Daiyong Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.